http://www.engineeringnews.co.za
R/€ = 15.96 Change: 0.10
R/$ = 13.98 Change: 0.20
Au 1222.03 $/oz Change: 9.13
Pt 845.50 $/oz Change: 9.48
 

Topic

Aspen sells global nutritional business

By: Tasneem Bulbulia     13th September 2018 Pharmaceutical manufacturer and supplier Aspen has concluded an agreement to sell its global nutritional business to French-based multinational dairy corporation Lactalis Group for a fully funded cash consideration of €739.8-million, or about R12.9-billion. The company disclosed this during a... 

Aspen mulls sale of infant formula unit

By: Reuters     11th September 2018 South African drug maker Aspen Pharmacare said on Tuesday it was in discussions to sell its global infant formula business, but did not give any further details. Aspen's infant milk formula business sells infant milk formula in the Asia-Pacific, Sub-Saharan Africa and Latin America, and has a... 

Aspen secures €3.4bn credit line

By: Reuters     17th May 2018 Aspen Pharmacare, Africa's biggest generic drugmaker, said on Thursday it had secured a €3.4-billion ($4-billion) credit facility for refinancing debt at three of its subsidiaries. Aspen, which has operations in 50 countries, said the facilities were 70 percent oversubscribed and would be used... 

Therapeutic brands help lift Aspen Pharmacare's H1 profit

By: Reuters     8th March 2018 South Africa's Aspen Pharmacare said on Thursday first-half earnings rose 26%, buoyed by a strong result from therapeutic focused brands and positive performance of the pharmaceutical business in its home market. Aspen, which counts developed Europe as its biggest revenue generator, has been... 

Aspen to start review of infant milk formula unit

By: Reuters     29th January 2018 Aspen Pharmacare will review its infant milk formula business with options including a sale to a strategic partner, Africa's biggest generic drugmaker said on Monday. The unit, which has factories in New Zealand, South Africa and Mexico, follows the approval by the China Food and Drug... 

Aspen denies knowledge of probe by US research group

By: African News Agency      9th January 2018 South African drug maker Aspen Pharmacare on Tuesday dismissed reports that its books were under scrutiny by an independent US research group, Viceroy Research, for possible accounting irregularities in its 2017 financial year. This comes after market speculation regarding a possible report into... 

Aspen welcomes DA-initiated price-fixing probe

By: African News Agency      24th April 2017 Aspen Pharmacare on Monday issued a statement welcoming reports that South Africa’s Competition Commission had agreed to take up a request from the country’s official opposition to investigate alleged anti-competitive conduct by the company. The South African pharmaceutical company said it... 

Aspen posts good interim results, despite headwinds

By: Megan van Wyngaardt     9th March 2017 Pharmaceutical company Aspen expects to report an overall stronger underlying performance in the second half of the current financial year, after a tough six months to December 31. During the six months under review, normalised headline earnings a share increased by 6% to 692c. 

Aspen full-year revenue, operating profit up

By: Leandi Kolver     10th September 2014 JSE-listed Aspen Pharmacare on Wednesday reported gross revenue of R31.4-billion for the year ended June 30, up 51% year-on-year, while operating profit increased 47% to R7.4-billion, driven largely by the group’s international business segment. Aspen also reported a 29% increase in headline... 

Tribunal to consider Nestlé, Aspen deal

By: Natalie Greve     5th December 2013 The Competition Tribunal is next week set to hear a case relating to the proposed acquisition of Pfizer Nutrition’s baby milk range of products by Aspen Nutritionals and will hear testimony from 17 witnesses, as well as a representative of the Competition Commission, on the possible impact of... 

‘Transformational’ transactions add momentum to Aspen’s global strategy

By: Leandi Kolver     12th September 2013 The completion of impending transactions with global healthcare companies MSD and GlaxoSmithKline (GSK) would add further momentum to JSE-listed pharmaceutical manufacturer Aspen Pharmacare Holdings’ international growth strategy, CEO Stephen Saad said on Thursday. The transactions would enable... 

First
Prev
1
Next
Last

Latest News

more

Latest Videos

more

About

Engineering News is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Mining Weekly
Research Channel Africa
Polity

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Engineering News is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options
Free daily email newsletter Register Now
Register Close